KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Net Cash Flow (2016 - 2025)

Merck (MRK) has disclosed Net Cash Flow for 17 consecutive years, with -$3.6 billion as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 258.23% to -$3.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $809.0 million through Dec 2025, down 87.93% year-over-year, with the annual reading at $809.0 million for FY2025, 87.93% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$3.6 billion at Merck, down from $10.2 billion in the prior quarter.
  • The five-year high for Net Cash Flow was $10.2 billion in Q3 2025, with the low at -$4.7 billion in Q1 2025.
  • Average Net Cash Flow over 5 years is $321.9 million, with a median of -$250.5 million recorded in 2022.
  • The sharpest move saw Net Cash Flow plummeted 2155.29% in 2021, then skyrocketed 245.29% in 2024.
  • Over 5 years, Net Cash Flow stood at -$1.7 billion in 2021, then surged by 164.57% to $1.1 billion in 2022, then tumbled by 272.52% to -$1.9 billion in 2023, then surged by 48.46% to -$1.0 billion in 2024, then tumbled by 258.23% to -$3.6 billion in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$3.6 billion, $10.2 billion, and -$1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.